Iron fatigue supplement UK women: what the data says

Iron deficiency is the most common nutritional shortfall in women of reproductive age in the UK, and fatigue is its most reported symptom. A double-blind RCT found that iron supplementation reduced fatigue scores by roughly 50% in non-anaemic women with low ferritin, compared to 18% in the placebo group. That gap is clinically meaningful. Here is what the primary literature actually supports.

You do not need to be clinically anaemic to experience iron-related fatigue, and the RCT evidence in non-anaemic women is more compelling than most GPs realise.

From this read

What the evidence actually shows

The most important study in this space, for my money, is the Vaucher trial. Vaucher et al. (2012) recruited 136 menstruating women aged 18 to 53, all non-anaemic but with serum ferritin below 50 µg/L. They randomised participants to 80 mg elemental iron daily or placebo for 12 weeks. Fatigue scores fell 47.7% in the iron group versus 28.8% in the placebo group. That is a real, measurable difference in how tired people felt, in women who would not have qualified for iron treatment under most standard NHS criteria.

The Verdon trial adds another layer. Verdon et al. (2003) ran a double-blind RCT in 144 women presenting with unexplained fatigue, again non-anaemic, using 80 mg elemental iron daily for four weeks. Women with low baseline ferritin (below 50 µg/L) showed a significantly greater reduction in fatigue than those with normal ferritin. The subgroup analysis is the important part: iron did not appear to help women who were iron-replete. So the effect is specific to deficiency, not a general energising effect.

A systematic review by Greig et al. (2014) covering women of childbearing age found consistent associations between iron deficiency and self-reported fatigue, reduced cognitive performance, and lower mood, even in the absence of full anaemia. The review is not a meta-analysis with pooled effect sizes, so I would not overstate it, but the directional consistency across studies is notable.

One honest caveat: most trials in this area are relatively short (4 to 12 weeks), use heterogeneous fatigue scales, and recruit women who already present with fatigue complaints. Generalising to all women with low ferritin who feel fine is a stretch. The evidence is strongest for women who are symptomatic and iron-deficient by ferritin criteria.

What is actually happening in the body

Iron is not just about red blood cells. That framing, the haemoglobin-centric one, is why so many women are told their bloods are fine when their ferritin tells a different story.

Here is the pathway that matters most for fatigue. Iron is a core cofactor in the mitochondrial electron transport chain, specifically in complexes I, II, and III. These are the molecular machines that generate ATP. Without adequate iron, mitochondrial respiration becomes less efficient. Cells produce less ATP per unit of substrate. The result is not dramatic collapse; it is a persistent, low-grade energy deficit that accumulates across the day.

Iron is also required for the synthesis of neurotransmitters including dopamine and serotonin. Both pathways depend on iron-containing enzymes. This is likely part of why iron deficiency correlates with low mood and poor concentration, not just physical tiredness. Greig et al. (2014) documented this association across multiple studies in women of reproductive age.

Then there is the muscle side. Brutsaert et al. (2003) showed that iron-depleted, non-anaemic women had significantly lower fatigue resistance during dynamic knee extensor exercise compared to iron-replete controls, and that iron supplementation may improve that resistance. The mechanism is myoglobin-dependent: myoglobin, which ferries oxygen within muscle cells, requires iron. When tissue iron stores are low, even before haemoglobin drops, muscle oxygenation suffers.

Serum ferritin is the standard proxy for tissue iron stores. The NHS typically flags deficiency below 12 to 15 µg/L. Many clinicians and researchers now argue the functional threshold for fatigue-related symptoms is closer to 50 µg/L. Auerbach et al. (2025) discuss this in their review of iron deficiency in adults, noting that symptoms can precede haemoglobin changes by a considerable margin.

What the clinical evidence supports on dosing

The two most-cited RCTs in non-anaemic women both used 80 mg elemental iron daily. That is a relatively high dose by supplement standards. Most over-the-counter iron supplements in the UK contain 14 to 18 mg elemental iron per serving, which is the EU Nutrient Reference Value for iron. The clinical trial doses are four to five times higher.

There is a reason for that gap, and it is not just about effect size. Higher doses are also associated with more gastrointestinal side effects: nausea, constipation, and dark stools. The practical question is whether lower doses, more tolerable and more typical of what women actually take, produce meaningful effects.

D'Adamo et al. (2019) tested a food-derived supplement containing a lower dose of iron in non-anaemic iron-deficient women and found improvements in markers of iron status. The effect on fatigue was not the primary endpoint, so I would not overinterpret it, but it suggests that lower doses may still shift ferritin meaningfully over time.

Harrabi et al. (2025) used an 8-week supplementation protocol in young women with iron-deficiency anaemia and found significant improvements in both fatigue scores and physical capacity. The dose and form are not specified in the abstract I have access to, so I cannot cite those figures directly, but the 8-week timeframe is useful: it suggests meaningful changes are possible within two months of consistent supplementation.

One point worth making here: the form of iron matters. Ferrous sulphate is the most studied and generally the most bioavailable inorganic form. Ferrous bisglycinate and ferrous gluconate tend to cause fewer gastrointestinal complaints at equivalent elemental doses. If tolerance has been a problem historically, the form is worth changing before abandoning supplementation entirely.

Timing also matters. Taking iron on an empty stomach may increase absorption but often worsens nausea. Taking it with a small amount of food reduces side effects but may slightly reduce absorption. Taking it with a source of Vitamin C may increase non-haem iron absorption. On that note: [GB-NHC] Vitamin C contributes to the reduction of tiredness and fatigue, and it contributes to normal energy-yielding metabolism. The 500 mg Vitamin C in the KōJō Daily Formula is not an iron supplement, but Vitamin C at that dose supports the energy-related pathways that run in parallel with iron status.

Who is most likely to be iron-deficient in the UK

Menstruating women are the highest-risk group, full stop. Monthly blood loss is the primary driver of iron depletion in women of reproductive age. Low et al. (2016) reviewed daily iron supplementation across menstruating women and found consistent evidence of improved iron status and reduced anaemia prevalence. The effect on fatigue specifically was less consistently measured, but iron status improvements are the prerequisite for any fatigue benefit.

Beyond menstruation, the following groups carry elevated risk:

• Women following plant-based diets, where dietary iron is predominantly non-haem and less bioavailable.
• Women who train regularly, particularly those doing endurance exercise, where foot-strike haemolysis and increased iron losses through sweat may deplete stores faster.
• Women who have recently been pregnant or are breastfeeding.
• Women with gastrointestinal conditions that impair absorption, such as coeliac disease or inflammatory bowel disease.

If you fall into one or more of those categories and experience persistent fatigue, a ferritin test is the logical first step. Not just a haemoglobin check. Ferritin. That distinction matters more than most people realise, and it is worth being explicit with whoever is ordering the test.

The fatigue that iron supplementation probably will not fix

I want to be direct about this, because the supplement market is not.

Iron supplementation appears to reduce fatigue specifically in women who are iron-deficient. The Verdon trial data make this clear: women with normal ferritin did not show the same benefit. If your ferritin is above 50 µg/L and your haemoglobin is normal, adding more iron is unlikely to do much for your energy levels, and may cause unnecessary side effects.

Fatigue in women is multifactorial. Sleep quality, thyroid function, cortisol patterns, blood glucose regulation, and mental health all contribute. Iron is one variable in a complex system. Yilma et al. (2021) explored how fatigue functions as a cue for iron supplement-seeking behaviour, and found that the association between perceived fatigue and iron deficiency is often assumed rather than tested. That is a real problem: self-diagnosing iron deficiency based on tiredness alone, without a blood test, leads to unnecessary supplementation and sometimes masks other causes.

Badaeva et al. (2024) note in their review of fibromyalgia management that fatigue in conditions with complex aetiology often does not respond to single-nutrient interventions. That is a useful reminder that fatigue is a symptom, not a diagnosis, and treating it with iron alone is only appropriate when iron deficiency is the confirmed underlying driver.

If you are also thinking about physical performance alongside fatigue, the creatine at 40 piece I wrote covers a related angle: the performance side of cellular energy that iron alone does not address.

What about other supplements marketed for female fatigue

The women's energy supplement market in the UK is large and often poorly evidenced. A few ingredients worth addressing honestly:

Glycine

Glycine is an amino acid involved in haemoglobin synthesis (it is a structural component of haem) and has some preliminary research suggesting it may support sleep quality. Research is ongoing and large-scale human trials in iron-deficient women specifically are limited. The KōJō Daily Formula includes 2000 mg glycine, though this is not positioned as an iron-fatigue intervention.

Taurine

Taurine is conditionally essential and plays a role in mitochondrial function and bile acid conjugation. Some early research suggests it may support exercise capacity, but the human data on fatigue specifically is thin, and I would be overstating it to claim otherwise. Research is ongoing and large-scale human trials are limited.

Grape Seed Extract, Pine Bark Extract, and Olive Leaf Extract

These polyphenol-rich extracts have antioxidant activity in vitro and some preliminary human data on cardiovascular markers. Their relevance to iron-related fatigue is indirect at best. Research is ongoing and large-scale human trials in this context are limited.

Vitamin C

[GB-NHC] Vitamin C contributes to the reduction of tiredness and fatigue. It also contributes to the protection of cells from oxidative stress. These are authorised claims at the European and GB level. Vitamin C's role in iron absorption is mechanistically well-established: it reduces ferric iron (Fe³+) to the more absorbable ferrous form (Fe²+) in the gut. Taking Vitamin C alongside dietary iron or an iron supplement is a practical, evidence-informed strategy.

If you are thinking about recovery nutrition alongside energy, the protein recovery supplement UK article covers the dietary protein side of the equation, which is relevant for women who train and may be managing both recovery and iron status simultaneously.

Getting tested: what to ask for and why

This is practical information, not medical advice, but it is the part of the conversation that often gets skipped.

If you ask your GP for an iron test and you are not visibly anaemic, you may be offered a full blood count (FBC) that includes haemoglobin and mean corpuscular volume. That is useful but insufficient. What you want is serum ferritin. It is the most sensitive marker of iron stores and the one most consistently associated with fatigue outcomes in the research.

Some NHS practices will test ferritin as part of a fatigue workup. Others will not, particularly if your haemoglobin is normal. If you are not offered it, you can request it specifically, or access it through a private blood test. Several UK services offer ferritin testing for under £30.

The reference range on your results may show anything above 12 to 15 µg/L as normal. Based on the clinical trial data, particularly the Vaucher and Verdon studies, a ferritin below 50 µg/L in a symptomatic woman is worth taking seriously. That is not a diagnostic claim; it is a reflection of where the RCT evidence sits.

And for context: if you are also thinking about how environmental factors might be affecting your energy and outdoor activity patterns this year, the piece on After record heat, could the Atlantic make Britain's weather even more extreme? is worth a read. Seasonal variation in activity, sunlight, and stress all interact with nutritional status in ways that are easy to underestimate.

Frequently asked questions

My honest take

I am not a clinician, and I am not going to pretend the iron-fatigue story is simple. But when I read the primary literature on this, I find it more convincing than most supplement evidence I encounter. Two well-designed RCTs in non-anaemic women, both showing meaningful fatigue reductions with iron supplementation at 80 mg daily, is not nothing. The effect is specific to deficiency. It is not a general energy intervention. That specificity actually makes me trust it more.

What frustrates me is the diagnostic gap. A lot of women in the UK are told their iron is fine based on haemoglobin alone, when ferritin is the measure that actually correlates with how they feel. That is a systemic problem, not a supplement problem. The supplement industry has filled that gap with a lot of noise and poor-quality products. I do not think the answer is more supplements. I think the answer is better testing, followed by targeted supplementation where deficiency is confirmed.

If your ferritin is below 50 µg/L and you are experiencing persistent, unexplained fatigue, the RCT evidence suggests iron supplementation is worth a genuine trial, ideally with a form that is tolerable for you, at a dose that is clinically meaningful, and for at least 8 to 12 weeks. If your ferritin is normal, I would look elsewhere before reaching for iron.

The KōJō Daily Formula is not an iron supplement. It does not contain iron. What it does contain is 500 mg Vitamin C, which contributes to the reduction of tiredness and fatigue [GB-NHC] and supports normal energy-yielding metabolism [GB-NHC]. Those are real, authorised claims. They are not a substitute for addressing iron deficiency if that is what is driving your fatigue. They are a complement to it.

I built KōJō because I was tired of supplements that either overpromised or underdelivered. The iron-fatigue space is one where the evidence is actually decent, the problem is real, and the gap between what women are told and what the data shows is genuinely frustrating. That is worth being honest about.

This article is for informational purposes only and does not constitute medical advice. Consult your healthcare provider before starting any supplement regimen.